Downstream of Tyrosine Kinase 1 and 2 Play Opposing Roles in CD200 Receptor Signaling

被引:54
|
作者
Mihrshahi, Robin [1 ]
Brown, Marion H. [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 185卷 / 12期
基金
英国医学研究理事会;
关键词
MACROPHAGE ACTIVATION; PROGNOSTIC-FACTOR; SURFACE-PROTEINS; DOWN-REGULATION; CELL; INHIBITION; FAMILY; MICE; CRKL; PHOSPHORYLATION;
D O I
10.4049/jimmunol.1002858
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CD200 receptor (CD200R) negatively regulates myeloid cells by interacting with its widely expressed ligand CD200. CD200R signals through a unique inhibitory pathway involving a direct interaction with the adaptor protein downstream of tyrosine kinase 2 (Dok2) and the subsequent recruitment and activation of Ras GTPase-activating protein (RasGAP). Ligand engagement of CD200R also results in tyrosine phosphorylation of Dok1, but this protein is not essential for inhibitory CD200R signaling in human myeloid cells. In this paper, we show that CD200R-induced phosphorylation of Dok2 precedes phosphorylation of Dok1, and that Dok2 and Dok1 recruit different downstream proteins. Compared with Dok2, Dok1 recruits substantially less RasGAP. In addition to binding RasGAP, Dok2 recruits the adaptor molecule Nck in response to ligand engagement of CD200R. CD200R-induced phosphorylation of Dok1 results in the recruitment of CT10 sarcoma oncogene cellular homologue-like (CrkL), whereas the closely related CT10 sarcoma oncogene cellular homologue interacts constitutively with Dok1. Knockdown of Dok1 or CrkL expression in U937 cells resulted in increased Dok2 phosphorylation and RasGAP recruitment to Dok2. These data are consistent with a model in which Dok1 negatively regulates Dok2-mediated CD200R signaling through the recruitment of CrkL. The Journal of Immunology, 2010, 185: 7216-7222.
引用
收藏
页码:7216 / 7222
页数:7
相关论文
共 50 条
  • [31] Receptor tyrosine kinase signaling in neurofibromatosis-2 - Associated tumors
    Karajannis, Matthias
    Zagzag, David
    Newcomb, Elizabeth
    Roehm, Pamela
    Roland, John
    Golfinos, John
    Wisoff, Jeffrey
    Allen, Jeffrey
    NEURO-ONCOLOGY, 2008, 10 (03) : 464 - 464
  • [32] Tyrosine-610 in the Receptor Kinase BAK1 Does Not Play a Major Role in Brassinosteroid Signaling or Innate Immunity
    Singh, Vijayata
    Perraki, Artemis
    Kim, Sang Y.
    Shrivastava, Stuti
    Lee, Jae H.
    Zhao, Youfu
    Schwessinger, Benjamin
    Oh, Man-Ho
    Marshall-Colon, Amy
    Zipfel, Cyril
    Huber, Steven C.
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [33] Does CD200/CD200R signalling bias the Th1/Th2 balance in inflammation?
    Liversidge, J
    McConachie, K
    Dawson, R
    Daniels, G
    Crane, I
    IMMUNOLOGY, 2005, 116 : 104 - 104
  • [34] The CD200 tolerance-signaling molecule and its receptor, CD200R1, are expressed in human placental villus trophoblast and in pen-implant decidua by 5 weeks' gestation
    Clark, David A.
    Arredondo, Jorge L.
    Dhesy-Thind, Sukhbinder
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2015, 112 : 20 - 23
  • [35] Inhibition of platelet-derived growth factor receptor tyrosine kinase and downstream signaling pathways by Compound C
    Kwon, Hyun Jin
    Kim, Go-Eun
    Lee, Yun Taek
    Jeong, Meong-Sook
    Kang, Insug
    Yang, Dongki
    Yeo, Eui-Ju
    CELLULAR SIGNALLING, 2013, 25 (04) : 883 - 897
  • [36] Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma
    Gui, Y.
    Yeganeh, M.
    Donates, Y-C
    Tobelaim, W-S
    Chababi, W.
    Mayhue, M.
    Yoshimura, A.
    Ramanathan, S.
    Saucier, C.
    Ilangumaran, S.
    ONCOGENE, 2015, 34 (46) : 5718 - 5728
  • [37] Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma
    Y Gui
    M Yeganeh
    Y-C Donates
    W-S Tobelaim
    W Chababi
    M Mayhue
    A Yoshimura
    S Ramanathan
    C Saucier
    S Ilangumaran
    Oncogene, 2015, 34 : 5718 - 5728
  • [38] From phosphorylation to phenotype-Recent key findings on kinase regulation, downstream signaling and disease surrounding the receptor tyrosine kinase MuSK
    Proemer, Jakob
    Barresi, Cinzia
    Herbst, Ruth
    CELLULAR SIGNALLING, 2023, 104
  • [39] CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes
    Tossidou, Irini
    Kardinal, Christian
    Peters, Imke
    Kriz, Wilhelm
    Shaw, Andrey
    Dikic, Ivan
    Tkachuk, Sergej
    Dumler, Inna
    Haller, Hermann
    Schiffer, Mario
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (10) : 7457 - 7464
  • [40] Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase
    Hynes, NE
    Lane, HA
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (01) : 141 - 150